FDANews
FDAnews Device Daily Bulletin

CLX INVESTMENT COMPANY ANNOUNCES SHIPMENTS OF INFECTIOUS DISEASE TESTS TO EUROPEAN MARKETS

Dec. 15, 2005

CLX Investment Company, Inc. today announced that portfolio investment Zonda, Inc. is continuing shipments of its HandiLab-C test for Chlamydia to European markets. A shipment of the personal use (over-the-counter) Chlamydia-C test was sent to the company's distributor for Scandinavia in late November for delivery to pharmacies across Norway.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051214005429&newsLang=en)